121 related articles for article (PubMed ID: 7539120)
1. Evaluation of the cytokine response in Kawasaki disease.
Eberhard BA; Andersson U; Laxer RM; Rose V; Silverman ED
Pediatr Infect Dis J; 1995 Mar; 14(3):199-203. PubMed ID: 7539120
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous tumor necrosis factor production in Kawasaki disease.
Lang BA; Silverman ED; Laxer RM; Lau AS
J Pediatr; 1989 Dec; 115(6):939-43. PubMed ID: 2585231
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-induced cytokine production in peripheral blood mononuclear cells: intracellular localization of tumor necrosis factor alpha and interleukin 1 beta detected with a three-color immunofluorescence technique.
de Bont ES; Niemarkt AE; Tamminga RY; Kimpen JL; Kamps WA; de Leij LH
Histochem Cell Biol; 1996 Dec; 106(6):593-8. PubMed ID: 8985748
[TBL] [Abstract][Full Text] [Related]
4. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.
Terai M; Jibiki T; Harada A; Terashima Y; Yasukawa K; Tateno S; Hamada H; Oana S; Niimi H; Matsushima K
J Leukoc Biol; 1999 May; 65(5):566-72. PubMed ID: 10331483
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA.
Horwitz DA; Wang H; Gray JD
Lupus; 1994 Oct; 3(5):423-8. PubMed ID: 7841998
[TBL] [Abstract][Full Text] [Related]
6. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum.
Furukawa S; Matsubara T; Yone K; Hirano Y; Okumura K; Yabuta K
Eur J Pediatr; 1992 Jan; 151(1):44-7. PubMed ID: 1728545
[TBL] [Abstract][Full Text] [Related]
7. [Peripheral blood monocyte/macrophages among mononuclear cells and serum tumor necrosis factor in patients with Kawasaki disease].
Matsubara T
Arerugi; 1988 Jul; 37(7):454-60. PubMed ID: 3214289
[No Abstract] [Full Text] [Related]
8. [Kawasaki disease. Immunological evaluation of 26 cases].
Krasovec S; Bezrodnik L; Gaillard MI; Carabajal P; Ginaca A; Vainstein E
Medicina (B Aires); 2001; 61(1):8-14. PubMed ID: 11265631
[TBL] [Abstract][Full Text] [Related]
9. Effect of Kawasaki disease on migration of human umbilical vein endothelial cells.
Sakata K; Kita M; Imanishi J; Onouchi Z; Liu Y; Mitsui Y
Pediatr Res; 1995 Oct; 38(4):501-5. PubMed ID: 8559600
[TBL] [Abstract][Full Text] [Related]
10. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.
Lin CY; Lin CC; Hwang B; Chiang B
J Pediatr; 1992 Dec; 121(6):924-6. PubMed ID: 1447658
[TBL] [Abstract][Full Text] [Related]
11. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease.
Maury CP; Salo E; Pelkonen P
J Lab Clin Med; 1989 May; 113(5):651-4. PubMed ID: 2715685
[TBL] [Abstract][Full Text] [Related]
12. Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis.
Eberhard BA; Laxer RM; Andersson U; Silverman ED
Clin Exp Immunol; 1994 May; 96(2):260-6. PubMed ID: 8187333
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease.
Furukawa S; Matsubara T; Jujoh K; Yone K; Sugawara T; Sasai K; Kato H; Yabuta K
Clin Immunol Immunopathol; 1988 Aug; 48(2):247-51. PubMed ID: 3390972
[TBL] [Abstract][Full Text] [Related]
14. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease.
Suzuki H; Uemura S; Tone S; Iizuka T; Koike M; Hirayama K; Maeda J
Eur J Pediatr; 1996 Apr; 155(4):291-6. PubMed ID: 8777922
[TBL] [Abstract][Full Text] [Related]
16. Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.
Ikeda K; Yamaguchi K; Tanaka T; Mizuno Y; Hijikata A; Ohara O; Takada H; Kusuhara K; Hara T
Clin Exp Immunol; 2010 May; 160(2):246-55. PubMed ID: 20015095
[TBL] [Abstract][Full Text] [Related]
17. Immunopathology and cytokine detection in the skin lesions of patients with Kawasaki disease.
Sato N; Sagawa K; Sasaguri Y; Inoue O; Kato H
J Pediatr; 1993 Feb; 122(2):198-203. PubMed ID: 8094096
[TBL] [Abstract][Full Text] [Related]
18. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
Kato M; Ayusawa M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
Pediatr Int; 2018 Apr; 60(4):342-348. PubMed ID: 29350882
[TBL] [Abstract][Full Text] [Related]
19. Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease.
Matsubara T; Umezawa Y; Tsuru S; Motohashi T; Yabuta K; Furukawa S
Scand J Rheumatol; 1997; 26(4):314-7. PubMed ID: 9310113
[TBL] [Abstract][Full Text] [Related]
20. The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease.
Lin CY; Lin CC; Hwang B; Chiang BN
Eur J Pediatr; 1991 Jan; 150(3):179-82. PubMed ID: 1904353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
